Authors:
Joloba, ML
Windau, A
Bajaksouzian, S
Appelbaum, PC
Hausdorff, WP
Jacobs, MR
Citation: Ml. Joloba et al., Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media, CLIN INF D, 33(9), 2001, pp. 1489-1494
Citation: Wp. Hausdorff et al., Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children, LANCET, 357(9260), 2001, pp. 950-952
Authors:
Hausdorff, WP
Bryant, J
Paradiso, PR
Siber, GR
Citation: Wp. Hausdorff et al., Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I, CLIN INF D, 30(1), 2000, pp. 100-121
Authors:
Hausdorff, WP
Bryant, J
Kloek, C
Paradiso, PR
Siber, GR
Citation: Wp. Hausdorff et al., The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II, CLIN INF D, 30(1), 2000, pp. 122-140
Authors:
Linhares, AC
Lanata, CF
Hausdorff, WP
Gabbay, YB
Black, RE
Citation: Ac. Linhares et al., Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity ofdiarrhea, PEDIAT INF, 18(11), 1999, pp. 1001-1006